Linking the sympathetic nervous system to the inflammasome: towards new therapeutics for atherosclerotic cardiovascular disease

Eur Heart J. 2018 Jan 1;39(1):70-72. doi: 10.1093/eurheartj/ehx374.

Authors

Mahir Karakas^{1

2}, Tina Haase^{1

2}, Tanja Zeller^{1

2}

Affiliations

¹ Clinic for General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany.
² German Center for Cardiovascular Research (DZHK e.V.), partner site Hamburg, Lübeck, Kiel, Germany.

No abstract available

Publication types

Comment

MeSH terms

Adrenergic Agents
Cardiovascular Diseases*
Fibrosis
Humans
Inflammasomes*
Inflammation
Interleukin-18
Sympathetic Nervous System

Substances

Adrenergic Agents
Inflammasomes
Interleukin-18